ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 464,09
-0,23%
DAX
21 394,93
-0,11%
Brent Oil
77,555
0,29%
Bitcoin
106 761,27
2,69%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Elite Pharmaceuticals Inc (QB) (ELTP) Cours

Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

USOTC
0,48404
-0,00596
( -1,22% )
Mis à jour : 19:00:29
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,48404
Prix Achat
0,4826
Prix Vente
0,485
Volume échangé
506 685
0,4751 Fourchette du Jour 0,4969
0,1213 Plage de 52 semaines 0,7598
Cap du marché
517,087M
Clôture Veille
0,49
Ouverture
0,49
Dernière Transaction
15000
@
0.48404
Dernière heure de transaction
19:00:29
Volume financier
US$ 244 857
VWAP
0,483253
Volume moyen (3 m)
1 656 274
Actions en circulation
1 068 273 108
Rendement du Dividende
-
Ratio Cours sur Bénéfices
25,53
Bénéfice par action (BPA)
0,02
Chiffre d'affairess
56,63M
Bénéfice net
20,11M

À propos de Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.elitepharma.com
Siège social
Carson City, Nevada, USA
Fondé
-
Elite Pharmaceuticals Inc (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker ELTP. Le dernier cours de clôture d'Elite Pharmaceuticals (QB) était de US$0,49. Au cours de la dernière année, les actions de Elite Pharmaceuticals (QB) ont été négociées dans une fourchette de prix de US$ 0,1213 à US$ 0,7598.

Elite Pharmaceuticals (QB) compte actuellement 1 068 273 108 actions en circulation. La capitalisation boursière d'Elite Pharmaceuticals (QB) est de US$523,45 million. Elite Pharmaceuticals (QB) a un ratio cours/bénéfice (ratio PE) de 25.53.

ELTP Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

26 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

02 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

18 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

28 Octobre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

23 Octobre 2024
Edgar (US Regulatory)

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition     Miami, FL – October 23, 2024 -- InvestorsHub NewsWire – EmergingGrowth.com, a leading...

23 Octobre 2024
InvestorsHub NewsWire

Form 8-K - Current report

10 Octobre 2024
Edgar (US Regulatory)

Form 8-K - Current report

27 Août 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.00596-1.216326530610.490.510.46976929040.49474539CS
4-0.07196-12.94244604320.5560.570.4512815490.51479205CS
120.033347.397381850450.45070.720.4516562740.5591571CS
260.28904148.2256410260.1950.75980.162623940990.46306346CS
520.27894136.0019502680.20510.75980.121316287870.38566024CS
1560.451041366.787878790.0330.75980.02689846560.24965066CS
2600.37404340.0363636360.110.75980.0239725770.17497495CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0,48404
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1 068 273 108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 523,45M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0,1213 to US$ 0,7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 25,53
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 9,06
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56,63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20,11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
400
TMPOQTempo Automation Holdings Inc (CE)
US$ 0,0009
(89 900,00%)
100
PKLBFPerk Labs Inc (CE)
US$ 0,0003
(29 900,00%)
50k
FUVVArcimoto Inc (CE)
US$ 0,0002
(19 900,00%)
628
FBCDFBC Holding Inc (PK)
US$ 0,0001
(9 900,00%)
3k
HOMUHoumu Holdings Ltd (CE)
US$ 0,000001
(-99,95%)
148
SHMPNaturalShrimp Incorporated (CE)
US$ 0,000001
(-99,75%)
1,4M
BWVIBlue Water Ventures International Inc (CE)
US$ 0,000001
(-99,75%)
117
SDCCQSmileDirectClub Inc (CE)
US$ 0,000001
(-99,75%)
74,05k
GENNGenesis Healthcare Inc (CE)
US$ 0,000001
(-99,50%)
3,06k
TKMOTekumo Inc (PK)
US$ 0,0004
(60,00%)
502,78M
PHILPHI Group Inc (PK)
US$ 0,00025
(25,00%)
288,43M
HMBLHUMBL Inc (PK)
US$ 0,0008
(0,00%)
139,84M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(-98,00%)
113,35M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0032
(-4,48%)
97,8M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés